This clinical trial is not currently recruiting participants. To find active clinical trials similar to this one please visit Clinical Trials Search. To be notified of new clinical trials as they become available visit Free Member Signup.

Study summary

Study 45796 Flyer

THE PARADIGME STUDY
This research study is testing investigational treatments (Lilotomab and Betalutin) to see how it works
for people whose follicular lymphoma (FL) has returned.

Medical Condition: Follicular Lymphoma
Study duration: 5 years
Phase: IIb
Study locations: United States and Canada

Qualified Participants Must:
  • Be at least 18 years of age
  • Have a diagnosis of Follicular Lymphoma
  • Have tried at least 2 treatments for FL
  • Have used rituximab or Obinutuzumab

Qualified Participants May Receive:

  • Reimbursement for travel


CLICK HERE

Study is available at

This study is being conducted NATIONWIDE! To find clinics conducting this study near you please use search feature below.

Study Locations